FDA 483 - California IVF Fertility Center - October 11, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of California IVF Fertility Center in Sacramento revealed significant deficiencies in donor testing and screening for communicable diseases. The firm failed to test oocyte and semen donors for West Nile Virus using an FDA-licensed NAT test and did not adequately screen donors for Zika Virus, West Nile Virus, TSEs (including CJD), and HIV. Additionally, the facility lacked established and maintained procedures for determining HCT/P donor eligibility, including specific procedures for testing and screening for various infectious agents.
ID · 8f614f2a-5f35-40d0-a1d8-0d394692dce9